Hasil Pencarian - Pascal Claudepierre

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)

    Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health ins... oleh Pascal Claudepierre, Laura Pina Vegas, Emilie Sbidian, Siham Iggui

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)

    Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance databas... oleh Pascal Claudepierre, Léa Bastard, Lea Hoisnard, Laura Pina Vegas, Emilie Sbidian

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data

    Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data oleh Adeline Ruyssen-Witrand, Cécile Luxembourger, Alain Cantagrel, Delphine Nigon, Pascal Claudepierre, Yannick Degboe, Arnaud Constantin

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France

    Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of... oleh Maxime Dougados, Pascal Claudepierre, Adeline Ruyssen-Witrand, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Julien Lucas, Emilie Desfleurs

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)

    Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA) oleh Maxime Dougados, Pascal Claudepierre, Adeline Ruyssen-Witrand, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Julien Lucas, Emilie Desfleurs

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort

    5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort oleh Sofia Ramiro, Désirée van der Heijde, Maxime Dougados, Anna Molto, Pascal Claudepierre, Alexandre Sepriano, Floris A van Gaalen, Queeny Madari, Daniel Wendling

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort

    Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort oleh Francis Berenbaum, Maxime Dougados, Laure Gossec, Anna Molto, Pascal Claudepierre, Adeline Ruyssen-Witrand, Bernard Combe, Alain Saraux, Chris Serrand, Thierry Lequerre, Daniel Wendling, Sandrine Alonso

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

    Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database oleh Léa Hoisnard, Bénédicte Lebrun-Vignes, Sébastien Maury, Matthieu Mahevas, Khalil El Karoui, Lydia Roy, Anissa Zarour, Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, Pierre Wolkenstein, Philippe Grimbert, Emilie Sbidian

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR

    Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBAR... oleh Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge, Robert G. Lambert, Robert Landewé, Anna Molto, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Maxime Dougados

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.

    Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort. oleh Gaetane Nocturne, Stephan Pavy, Saida Boudaoud, Raphaèle Seror, Philippe Goupille, Philippe Chanson, Désirée van der Heijde, Floris van Gaalen, Francis Berenbaum, Xavier Mariette, Karine Briot, Antoine Feydy, Pascal Claudepierre, Philippe Dieudé, Joanne Nithitham, Kimberly E Taylor, Lindsey A Criswell, Maxime Dougados, Christian Roux, Corinne Miceli-Richard

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol

    Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol oleh Jérémie Sellam, Laure Gossec, Pascal Claudepierre, Axel Finckh, Grégoire Cormier, Renaud Felten, Emmanuelle Dernis, Arnaud Constantin, Hubert Marotte, Philippe Goupille, Thierry Schaeverbeke, Athan Baillet, Anne Tournadre, Tristan Pascart, Maxime Breban, Valerie Devauchelle, Thierry Lequerre, Christian Jorgensen, Eric Lespessailles, Elisabeth Gervais, Daniel Wendling, Cédric Lukas, Corinne Miceli, Emilie Presles, Stephan Pavy, Jean-Hugues Salmon, Christian Marcelli, Olivier Brocq, Beatrice Bouvard, Benoit Le Goff, Florence Rancon, Theodora Bejan-Angoulvant, Elisa Dalix, Madjid Akrour, Liliane De Araujo, Christian H Roux

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: